索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]丁子婕,孙玉喜,张艳丽,等.心电图在扩张型心肌病精准诊断评估中的价值[J].国际心血管病杂志,2023,04:221-224.
点击复制

心电图在扩张型心肌病精准诊断评估中的价值(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年04期
页码:
221-224
栏目:
综述
出版日期:
2023-07-30

文章信息/Info

Title:
-
作者:
丁子婕; 孙玉喜; 张艳丽; 司金萍; 夏云龙; 刘莹
116011 大连医科大学附属第一医院心血管内科通信作者：刘莹， E-mail：yingliu.med@gmail.com
Author(s):
-
关键词:
心电图; 扩张型心肌病; 基因; 精准诊断
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.04.008
文献标识码:
-
摘要:
扩张型心肌病（DCM）是一组异质性心肌病，心电图有助于识别特殊基因型DCM，是评估和临床管理的有效工具。该文介绍心电图在DCM的精准诊断及危险分层中的价值，以期为临床DCM患者进行多维度评估和管理提供依据。
Abstract:
-

参考文献/References

[1]Jordan E, Peterson L, Ai T, et al. Evidence-based assessment of genes in dilated cardiomyopathy[J]. Circulation, 2021, 144(1):7-19.
[2]Finocchiaro G, Merlo M, Sheikh N, et al. The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy[J]. Eur J Heart Fail, 2020, 22(7):1097-1107.
[3]Ware JS, Li J, Mazaika E, et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies[J]. N Engl J Med, 2016, 374(3):233-241.
[4]Choi SH, Weng LC, Roselli C, et al. Association between titin loss-of-function variants and early-onset atrial fibrillation[J]. JAMA, 2018, 320(22):2354-2364.
[5]Akhtar MM, Lorenzini M, Cicerchia M, et al. Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene[J]. Circ Heart Fail, 2020, 13(10):e006832.
[6]Valverde-Gómez M, Ruiz-Curiel A, Melendo-Viu M, et al. Electrocardiogram changes in the spectrum of TTNtv dilated cardiomyopathy: accuracy and predictive value of a new index for LV-changes identification[J]. Heart Lung Circ, 2021, 30(10):1487-1495.
[7]Yokokawa T, Ichimura S, Hijioka N, et al. Case reports of a c.475G＞T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death[J]. BMC Cardiovasc Disord, 2019, 19(1):298.
[8]Porcu M, Corda M, Pasqualucci D, et al. A very long-term observation of a family with dilated cardiomyopathy and overlapping phenotype from lamin A/C mutation[J]. J Cardiovasc Med (Hagerstown), 2021, 22(1):53-58.
[9]Bennett R, Campbell T, Eslick A, et al. Ventricular tachycardia in a patient with dilated cardiomyopathy caused by a novel mutation of lamin A/C gene: insights from features on electroanatomic mapping, catheter ablation and tissue pathology[J]. Heart Lung Circ, 2021, 30(2):310-317.
[10] Kumar S, Baldinger SH, Gandjbakhch E, et al. Long-term arrhythmic and nonarrhythmic outcomes of lamin A/C mutation carriers[J]. J Am Coll Cardiol, 2016, 68(21):2299-2307.
[11] Begay RL, Graw SL, Sinagra G, et al. Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures[J]. JACC Clin Electrophysiol, 2018, 4(4):504-514.
[12] Ortiz-Genga MF, Cuenca S, Dal Ferro M, et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies[J]. J Am Coll Cardiol, 2016, 68(22):2440-2451.
[13] Huang YS, Xing YL, Li HW. Heterozygous desmin gene (DES) mutation contributes to familial dilated cardiomyopathy[J]. J Int Med Res, 2021, 49(4):3000605211006598.
[14] Clemen CS, Herrmann H, Strelkov SV, et al. Desminopathies:pathology and mechanisms[J]. Acta Neuropathol, 2013, 125(1):47-75.
[15] Doisne N, Waldmann V, Redheuil A, et al. A novel gain-of-function mutation in SCN5A responsible for multifocal ectopic Purkinje-related premature contractions[J]. Hum Mutat, 2020, 41(4):850-859.
[16] Wilde AAM, Amin AS. Clinical spectrum of SCN5A mutations: long QT syndrome, brugada syndrome, and cardiomyopathy[J]. JACC Clin Electrophysiol, 2018, 4(5):569-579.
[17] Vakhrushev Y, Kozyreva A, Semenov A, et al. RBM20-associated ventricular arrhythmias in a patient with structurally normal heart[J]. Genes (Basel), 2021, 12(1):94.
[18] Kayvanpour E, Sedaghat-Hamedani F, Amr A, et al. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals[J]. Clin Res Cardiol, 2017, 106(2):127-139.
[19] Parikh VN, Caleshu C, Reuter C, et al. Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy[J]. Circ Heart Fail, 2019, 12(3):e005371.
[20] Bleijendaal H, Ramos LA, Lopes RR, et al. Computer versus cardiologist: is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?[J]. Heart Rhythm, 2021, 18(1):79-87.
[21] Gentile PE, Paldino A, Cannatà A, et al. Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates[J]. Int J Cardiol, 2019, 278:180-185.
[22] Nuzzi V, Cannatà A, Manca P, et al. Atrial fibrillation in dilated cardiomyopathy: outcome prediction from an observational registry[J]. Int J Cardiol, 2021, 323:140-147.
[23] Losurdo P, Stolfo D, Merlo M, et al. Early arrhythmic events in idiopathic dilated cardiomyopathy[J]. JACC: Clin Electrophysiol, 2016, 2(5):535-543.
[24] Marume K, Noguchi T, Kamakura T, et al. Prognostic impact of multiple fragmented QRS on cardiac events in idiopathic dilated cardiomyopathy[J]. Europace, 2021, 23(2):287-297.
[25] Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary[J]. Heart Rhythm, 2019, 16(11):e373-e407.
[26] Merlo M, Zaffalon D, Stolfo D, et al. ECG in dilated cardiomyopathy: specific findings and long-term prognostic significance[J]. J Cardiovasc Med (Hagerstown), 2019, 20(7):450-458.
[27] Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol, 2018, 72(14):e91-e220.
[28] Micaglio E, Monasky MM, Bernardini A, et al. Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel TTN frameshift mutation[J]. Int J Mol Sci, 2021, 22(2):670.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（82170385， U1908209）
（收稿：2022-03-24 修回2023-03-01）
更新日期/Last Update: 2023-08-01